By Canadian Press

Health Canada receives submission to approve Moderna’s COVID-19 vaccine for kids

Nov 16, 2021 | 11:00 AM

OTTAWA — Health Canada says it has received a submission from Moderna to authorize use of its COVID-19 vaccine for children aged six to 11.

The agency says it will prioritize the review of the submission, while maintaining high scientific standards for safety, efficacy and quality.

It says the assessment will consider clinical trial data and emerging research about the impacts of COVID-19 in children to determine if the benefits of the vaccine outweigh the risks in this age group.

Health Canada is currently reviewing Pfizer-BioNTech’s submission for approval of its COVID-19 vaccine for children aged five to 11, and officials have indicated that a decision could come within the month.

The regulator says it’s monitoring the rollout of the Pfizer-BioNTech shot for children in the U.S., where the vaccine was authorized for use earlier this month.

Raiders AGM

Raiders impact on Prince Albert local economy continues to go up: AGM report

4h ago

Court proceedings

'The impact of this trauma will echo for generations': court case surrounding La Ronge woman's death reaches conclusion

Dec 11, 2024

Going Global

P.A.'s Zablocki named to Team Canada for U18 Women's World Championships

Dec 11, 2024

The general manager of Moderna Canada has said interim data for its pediatric vaccine shows a strong safety profile as well as a strong immune response.

This report by The Canadian Press was first published Nov. 16, 2021.

The Canadian Press